[Effects of oral administration of PSK on immune responses. I. Correlation of in vivo effects with in vitro biological activities].
Tsuchitani
T
T
Nio
Y
Y
Imai
S
S
Shiraishi
T
T
Kan
N
N
Ohgaki
K
K
Tobe
T
T
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000284:Administration, Oral; D000818:Animals; D002478:Cells, Cultured; D005591:Chemical Fractionation; D003602:Cytotoxicity, Immunologic; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D051379:Mice; D008970:Molecular Weight; D011509:Proteoglycans / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; C010770:polysaccharide-K